Prevalence of mycoplasma pneumoniae in patients with community-acquired pneumonia at Tishreen University Hospital in Lattakia

Authors

  • Haissam Yazigi Tishreen University
  • Malek Hejazie Tishreen University
  • Osama Dwebeh Tishreen University

Abstract

Mycoplasma pneumoniae is one of the most common causes of community acquired pneumonia, which is considered an important common disease that may lead to death.

The study aims to determine the prevalence of mycoplasma pneumoniae in community-acquired pneumonia patients by investigating IgM antibodies by the ELISA method in adult patients diagnosed with community acquired pneumonia at Tishreen University Hospital in Latakia

A cross-sectional study included 90 patients diagnosed with radiologically and clinically acquired community-acquired pneumonia, tuberculosis patients, immuno compromised and hospital pneumonia patients were excluded. Patients were distributed between 55 males and 35 females, with ages ranging from 15-86 years.

The prevalence of mycoplasma pneumoniae in community-acquired pneumonia patients was 5.6% of the studied sample

The study did not show a correlation between the patient’s age, gender, and CRP value, with the positive test, i.e. the presence of Mycoplasma pneumoniae.

The study showed that mycoplasma pneumoniae is an important cause of community-acquired pneumonia, and that the test for mycoplasma pneumoniae antibodies is a good and fast test for detecting the presence of Mycoplasma pneumoniae that can be used routinely and benefit from the diagnosis of pneumonia caused by mycoplasma pneumoniae, which helps in the appropriate selection of antibiotics and thus reduce the random use of these antibiotics

Author Biographies

Haissam Yazigi, Tishreen University

Professor, Dept of Laboratory Medicine,  Faculty of Medicine

Malek Hejazie, Tishreen University

Associate Professor, Dept of Pneumology,  Faculty of Medicine

Osama Dwebeh, Tishreen University

Postgraduate student, Dept of Laboratory Medicine, Faculty of Medicine

Downloads

Published

2021-10-28

How to Cite

1.
يازجي ه, حجازية م, دويبة أ. Prevalence of mycoplasma pneumoniae in patients with community-acquired pneumonia at Tishreen University Hospital in Lattakia. Tuj-hlth [Internet]. 2021Oct.28 [cited 2024Apr.18];43(5). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/11016

Issue

Vol. 43 No. 5 (2021): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 3 4 > >>